Bionor holding as

See also: Bianor holding ad

Keywords Suggestions

Bionor holding as

( Please select at least 2 keywords )

Related websites

Bionor Holding AS

  • Bionor has acquired its 3rd HIV vaccine candidate, Vacc-CRX
  • Oslo, January 10, 2019 The acquisition is in the form of an exchange of patents and rights between Bionor and Immunor AS
  • During Bionor’s equity raise in December 2017, Bionor pledged to dispose of all its non-HIV activities
  • These activities have now been transferred to Immunor

Bionorholding.com   DA: 17 PA: 17 MOZ Rank: 35

Bionor Holding Company Profile

  • Bionor Holding (formerly Bionor Pharma) is a biopharmaceutical company
  • It focuses on advancing its proprietary therapeutic vaccines Vacc-4x and Vacc-C5 towards a …

Craft.co   DA: 8 PA: 15 MOZ Rank: 25

Bionor has acquired its 3rd HIV

  • Vacc-CRX aims to prevent binding between gp 120 V3 loop and CCR5/CXCR4 co-receptors and is expected to carry neutralizing properties
  • This 3 rd principle in Bionor´s HIV project portfolio will therefore in combination with Bionor’s Vacc-4x and Vacc-C5 constitute a strong addition to Bionor’s Functional HIV Cure strategy.

Bionorholding.com   DA: 17 PA: 50 MOZ Rank: 70

BIONOR HOLDING AS · Karenslyst Alle 6, Oslo, NO-03, 0278, NO

  • BIONOR HOLDING AS (LEI# 2549009SYPDM9Y262725) is a legal entity registered with Bloomberg Finance L.P.
  • The address is Karenslyst Alle 6, Oslo, NO-03, 0278, NO.

Opencorpdata.com   DA: 16 PA: 25 MOZ Rank: 45

Bionor Holding AS

  • Bionor Holding AS | 502 följare på LinkedIn
  • Bionor's mission is to enable the immune system to fight HIV infection
  • Bionor is the first company, which has successfully completed a clinical trial using the shock and kill approach, thereby creating a strong foundation for further advancing its therapeutic vaccine Vacc-4x and Vacc-C5 in combination with other agents towards a …

Se.linkedin.com   DA: 15 PA: 26 MOZ Rank: 46

Bionor Holding AS

  • View Bionor Holding AS (bionorholding.com) location in Oslo, Norway , revenue, industry and description
  • Find related and similar companies as well as employees by title and much more.

Zoominfo.com   DA: 16 PA: 30 MOZ Rank: 52

Andres Schjønhaug Susrud

  • University of Oslo (UiO) Rapporter denne profilen Aktivitet Kære Netværk, Efter lidt mere end 2,5 år i PFA Pension, har jeg i dag haft første arbejdsdag i ATP, hvor jeg er startet i rollen som Head Of Finance… Likt av Andres

No.linkedin.com   DA: 15 PA: 42 MOZ Rank: 64

Bionor Pharma Has Acquired Solon

Bionor Pharma ASA has entered into an agreement to acquire the entire share capital of Solon Eiendom AS for a total consideration of approximately NOK 1 billion (EUR 110M) settled by issuing 6,666,666,666 new shares in Bionor Pharma ASA at NOK 0.15 (EUR 0.02) per share to the sellers of Solon Eiendom, Alden AS, Dukat AS, Hortulan AS, John Galt Invest AS, …

Nordicpropertynews.com   DA: 22 PA: 50 MOZ Rank: 80

amcure – amcure GmbH

  • amcure leverages its in-depth knowledge of CD44 target biology to develop a novel therapeutic approach to treat metastatic squamous tumors
  • In cancer, blocking the extracellular target CD44v6 has a beneficial effect on several relevant receptor tyrosine kinase pathways
  • Our first-in-class CD44v6-inhibitor AMC303 entered clinical development in

Amcure.com   DA: 10 PA: 10 MOZ Rank: 29

Bionor Pharma VentureRadar

  • Similar Companies: Inovio Pharmaceuticals USA Listed INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases
  • INOVIO is the first and only company to have clinically demonstrated that a DNA medicine can be …

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 80

Bionor Pharma ASA: Bionor Pharma announces the acquisition

Bionor Pharma ASA: Bionor Pharma announces the acquisition of Solon Eiendom and fully underwritten private placement and MRD Holding AS (owned by Simen Thorsen) and Solon AS (owned by Tore

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 78

News & Events

  • amcure is sponsored by a grant from the German Ministry of Education and Research
  • Short description: Development of a novel compound for the treatment of metastasizing cancers

Amcure.com   DA: 10 PA: 13 MOZ Rank: 35

Bionor Immuno AS

  • Nutri Pharma's Vacc-C5 to be prepared for phase I/II clinical trial
  • Based on encouraging results from pre-clinical research, Nutri Pharma ASA's wholly owned subsidiary Bionor Immuno AS, has announced that it will take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 towards phase I/II clinical trial.

Bionity.com   DA: 15 PA: 41 MOZ Rank: 69

Research & Development

  • Along with a comprehensive biomarker program, amcure has started a two part Phase I/Ib trial for AMC303 in October 2016
  • The trial, conducted in Belgium and Spain, is designed to assess the safety, tolerability and pharmacokinetics of multiple and increasing doses of AMC303 as monotherapy in patients with advanced

Amcure.com   DA: 10 PA: 22 MOZ Rank: 46

Bionor Pharma announces the acquisition of Solon Eiendom

Bionor is the first company, which has successfully completed a clinical trial using the shock and kill approach, thereby creating a strong foundation for further advancing its therapeutic vaccine

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 86

Bionor Immuno AS

  • Headquarters Regions Nordic Countries, Scandinavia
  • Contact Email [email protected]
  • Bionor Immuno AS, a biomedical drug development company, engages in developing therapeutic and preventive vaccines.

Crunchbase.com   DA: 18 PA: 30 MOZ Rank: 64

Platform technology

  • Today, we know that some of these forms such as vulnerable spots, which are the targets for the vaccines Bionor Holding are developing
  • A combination of modified peptides (small protein fragments) and an appropriate adjuvant drives specific responses either towards antibody-responses (including Th2), or T-cell / Cell-mediated responses

Immunor.com   DA: 11 PA: 21 MOZ Rank: 49

Inhibio LinkedIn

Inhibio is a venture capital funded R&D company that aims at developing efficient and environmentally friendly antifouling solutions for the marine industry.

Linkedin.com   DA: 16 PA: 16 MOZ Rank: 50

Aslak Aslaksen's email & phone Bionor

  • Scouring the web at all hours of the night wasn't gonna cut it
  • RocketReach has given us a great place to start
  • Our workflow has solid direction now - we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering.

Rocketreach.co   DA: 14 PA: 30 MOZ Rank: 63

Ticketbird LinkedIn

Oslo, Bionor Holding AS Lime Technologies Norway AS Computer Software Oslo, Oslo Sprout & Co Restaurants Cbio A/S Biotechnology Søborg, Capital Region

Linkedin.com   DA: 16 PA: 19 MOZ Rank: 55

Søren Keller – Projektchef for

  • Bionor Holding AS 1 år 6 måneder SVP, COO & interim CFO Bionor Holding AS feb
  • Olso Area, Norway/Copenhagen Area, Denmark Head of operations & finance at Bionor Pharma ASA listed and traded on the Norwegian Stock Exchange
  • - Setting up and operationalizing cross national organization

Dk.linkedin.com   DA: 15 PA: 16 MOZ Rank: 52

Arctic Pharma AS

  • Arctic Pharma AS is a privately held start-up company founded in 2012
  • We are committed to developing innovative anti-cancer drugs by exploiting the “sweet tooth” of cancer cells and their

Linkedin.com   DA: 16 PA: 25 MOZ Rank: 63

Bionoor.com 1 year, 166 days left

  • Bionor has acquired its 3rd HIV vaccine candidate, Vacc-CRX; Oslo, January 10, 2019 The acquisition is in the form of an exchange of patents and rights between Bionor and Immunor AS; During Bionor’s equity raise in December 2017, Bionor pledged to dispose of all its non-HIV activities

Site-stats.org   DA: 14 PA: 13 MOZ Rank: 50

Massive Growth of Immunogenetics Market by 2027 AbbVie

Immunogenetics is defined as a branch of science that analyses the relationship between immune system and genetics while comprises of all …

Unlvrebelyell.com   DA: 21 PA: 50 MOZ Rank: 95

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
The-handyman-company.com 228 days leftGoDaddy.com, LLCColoCrossing
Milner.com3 years, 354 days leftNetwork Solutions, LLCMilner Technologies, Inc.
Crossfithale.com 342 days leftGoDaddy.com, LLCGoogle LLC
Cakeontime.com 229 days leftBigRock Solutions LtdPDR
Bpbasl.com 22 days leftGoDaddy.com, LLCThe Endurance International Group, Inc.
Bbwmt.com 23 days leftNetwork Solutions, LLCEGIHosting
Twobrotherspizzamiami.com 227 days leftTurnCommerce, Inc. DBA NameBright.comAmazon Technologies Inc.
Turnerroofing.com 234 days leftGoDaddy.com, LLCGoogle LLC
Herbal-ange.com 84 days leftGMO Internet, Inc. d/b/a Onamae.comAmazon Technologies Inc.
Learnaidonline.com 332 days leftGoDaddy.com, LLCCloudflare, Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]